Natera, Inc. (NTRA)
NASDAQ: NTRA · Real-Time Price · USD
123.67
+0.23 (0.19%)
Nov 5, 2024, 11:14 AM EST - Market open
Natera Market Cap
Natera has a market cap or net worth of $15.18 billion as of November 5, 2024. Its market cap has increased by 224.96% in one year.
Market Cap
15.18B
Enterprise Value
14.82B
1-Year Change
224.96%
Ranking
Category
Stock Price
$122.73
Market Cap Chart
Since July 2, 2015, Natera's market cap has increased from $1.10B to $15.18B, an increase of 1,278.44%. That is a compound annual growth rate of 32.39%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 4, 2024 | 15.27B | 102.85% |
| Dec 29, 2023 | 7.53B | 91.96% |
| Dec 30, 2022 | 3.92B | -55.62% |
| Dec 31, 2021 | 8.83B | 3.98% |
| Dec 31, 2020 | 8.50B | 225.28% |
| Dec 31, 2019 | 2.61B | 202.62% |
| Dec 31, 2018 | 863.10M | 78.55% |
| Dec 29, 2017 | 483.40M | -21.19% |
| Dec 30, 2016 | 613.40M | 13.59% |
| Dec 31, 2015 | 540.00M | -50.96% |
View and export this data all the way back to 2015.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Insulet | 16.63B |
| Align Technology | 15.77B |
| Tenet Healthcare | 15.44B |
| Revvity | 15.39B |
| Avantor | 15.35B |
| Summit Therapeutics | 14.72B |
| Incyte | 14.59B |
| Genmab | 14.40B |